Heterogeneity in response to repeated intranasal oxytocin in schizophrenia and autism spectrum disorders: A meta‐analysis of variance

D Martins, M Paduraru… - British Journal of …, 2022 - Wiley Online Library
Intranasal oxytocin (OT) has been suggested as a putative adjunctive treatment for patients
with schizophrenia and autism spectrum disorders (ASD). Here, we examine available …

Heterogeneity in response to repeated intranasal oxytocin in schizophrenia and autism spectrum disorders: A meta-analysis of variance.

D Martins, M Paduraru, Y Paloyelis - British Journal of …, 2021 - europepmc.org
Intranasal oxytocin (OT) has been suggested as a putative adjunctive treatment for patients
with schizophrenia and autism spectrum disorders (ASD). Here, we examine available …

Heterogeneity in response to repeated intranasal oxytocin in schizophrenia and autism spectrum disorders: a meta-analysis of variance

DA Martins, M Paduraru, Y Paloyelis - British Journal of …, 2021 - kclpure.kcl.ac.uk
Intranasal oxytocin (OT) has been suggested as a putative adjunctive treatment for patients
with schizophrenia and autism spectrum disorders (ASD). Here, we examine available …

Heterogeneity in response to repeated intranasal oxytocin in schizophrenia and autism spectrum disorders: A meta‐analysis of variance

D Martins, M Paduraru, Y Paloyelis - British Journal of Pharmacology, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: label/>< jats: p> Intranasal oxytocin (OT) has been suggested as a
putative adjunctive treatment for patients with schizophrenia and autism spectrum disorders …

Heterogeneity in response to repeated intranasal oxytocin in schizophrenia and autism spectrum disorders: A meta-analysis of variance

D Martins, M Paduraru… - British journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Intranasal oxytocin (OT) has been suggested as a putative adjunctive treatment for patients
with schizophrenia and autism spectrum disorders (ASD). Here, we examine available …